News
STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...
Mean participant age at baseline was about 50 in NHS members and 54 in the HPFS. Median follow-up was about 10 years in both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results